These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3100799)
1. Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths. Coy DH; Murphy WA; Lance VA; Heiman ML J Med Chem; 1987 Jan; 30(1):219-22. PubMed ID: 3100799 [TBL] [Abstract][Full Text] [Related]
2. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. Coy DH; Hocart SJ; Murphy WA Eur J Pharmacol; 1991 Nov; 204(2):179-85. PubMed ID: 1806385 [TBL] [Abstract][Full Text] [Related]
3. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP Peptides; 1994; 15(3):489-95. PubMed ID: 7937325 [TBL] [Abstract][Full Text] [Related]
4. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes. Friedman AR; Ichhpurani AK; Brown DM; Hillman RM; Krabill LF; Martin RA; Zurcher-Neely HA; Guido DM Int J Pept Protein Res; 1991 Jan; 37(1):14-20. PubMed ID: 1904406 [TBL] [Abstract][Full Text] [Related]
5. Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor. Coy DH; Murphy WA; Lance VA; Heiman ML Peptides; 1986; 7 Suppl 1():49-52. PubMed ID: 3092197 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid. Sato K; Hotta M; Kageyama J; Chiang TC; Hu HY; Dong MH; Ling N Biochem Biophys Res Commun; 1987 Dec; 149(2):531-7. PubMed ID: 3122736 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies on the N-terminal region of growth hormone releasing factor. Coy DH; Murphy WA; Sueiras-Diaz J; Coy EJ; Lance VA J Med Chem; 1985 Feb; 28(2):181-5. PubMed ID: 3918170 [TBL] [Abstract][Full Text] [Related]
8. Potent long-acting growth hormone releasing factor analogues. Rivier J; Rivier C; Galyean R; Yammamoto G; Vale W Ann N Y Acad Sci; 1988; 527():44-50. PubMed ID: 3133968 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622 [TBL] [Abstract][Full Text] [Related]
10. 1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs. Kloosterman DA; Scahill TA; Hillman RM; Cleary DL; Kubiak TM Pept Res; 1991; 4(2):72-8. PubMed ID: 1667740 [TBL] [Abstract][Full Text] [Related]
11. New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity. Mezö I; Kovács M; Szöke B; Szabó EZ; Horváth J; Makara GB; Rappay G; Tamás J; Teplán I J Endocrinol Invest; 1993 Nov; 16(10):793-8. PubMed ID: 8144853 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Izdebski J; Pinski J; Horvath JE; Halmos G; Groot K; Schally AV Proc Natl Acad Sci U S A; 1995 May; 92(11):4872-6. PubMed ID: 7761415 [TBL] [Abstract][Full Text] [Related]
13. Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region. Hocart SJ; Murphy WA; Coy DH J Med Chem; 1990 Jul; 33(7):1954-8. PubMed ID: 2141879 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Ling N; Baird A; Wehrenberg WB; Ueno N; Munegumi T; Brazeau P Biochem Biophys Res Commun; 1984 Sep; 123(2):854-61. PubMed ID: 6435620 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Felix AM; Heimer EP; Wang CT; Lambros TJ; Fournier A; Mowles TF; Maines S; Campbell RM; Wegrzynski BB; Toome V Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952 [TBL] [Abstract][Full Text] [Related]
18. Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary. Gaudreau P; Boulanger L; Abribat T J Med Chem; 1992 May; 35(10):1864-9. PubMed ID: 1534126 [TBL] [Abstract][Full Text] [Related]
19. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526 [TBL] [Abstract][Full Text] [Related]
20. Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs. Stevenson CL; Friedman AR; Kubiak TM; Donlan ME; Borchardt RT Int J Pept Protein Res; 1993 Dec; 42(6):497-503. PubMed ID: 8307680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]